ResMed Inc (ResMed) develops, manufactures and distributes medical equipment for the diagnosis, treatment and management of respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include airflow generators such as continuous positive airway pressure (CPAP) devices, auto-bilevel devices, variable positive airway pressure (VPAP) devices, automatic positive airway pressure (APAP) devices, humidifiers, and ventilation products; masks; headgear; accessories; motors; diagnostic products; and data/patient management products. The company sells its products to sleep clinics, home healthcare dealers and third party payers. It operates through a network of wholly-owned subsidiaries, direct offices and independent distributors in the Americas, Europe and Asia-Pacific. ResMed is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ResMed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- ResMed Inc Company Overview
- ResMed Inc Company Snapshot
- ResMed Inc Pipeline Products and Ongoing Clinical Trials Overview
- ResMed Inc - Pipeline Analysis Overview
- Business Description
- ResMed Inc - Key Facts
- ResMed Inc - Major Products and Services
- ResMed Inc Pipeline Products by Development Stage
- ResMed Inc Ongoing Clinical Trials by Trial Status
- ResMed Inc Pipeline Products Overview
- Breezhaler Inhaler - Add On Sensor
- Breezhaler Inhaler - Add On Sensor Product Overview
- Connected Metered Dose Inhaler
- Connected Metered Dose Inhaler Product Overview
- Leo
- Leo Product Overview
- Leo Device
- Leo Device Product Overview
- Leo Device Clinical Trial
- Masksense
- Masksense Product Overview
- Mitigait
- Mitigait Product Overview
- Monterey Pneumatic Compression Device
- Monterey Pneumatic Compression Device Product Overview
- Smart Device - Cardiac Health
- Smart Device - Cardiac Health Product Overview
- ResMed Inc - Key Competitors
- ResMed Inc - Key Employees
- ResMed Inc - Key Employee Biographies
- ResMed Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ResMed Inc, Recent Developments
- Aug 03, 2023: ResMed Announces Results for the Fourth Quarter of Fiscal Year 2023
- Jun 27, 2023: Hospice Dynamix and Matrixcare Forge Groundbreaking Partnership to Offer Advanced Ai-Powered Ehr Integration to Hospice Care Providers
- May 02, 2023: ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
- Apr 27, 2023: ResMed announces results for the third quarter of fiscal year 2023
- Apr 06, 2023: ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
- Oct 27, 2022: ResMed Announces Results for the First Quarter of Fiscal Year 2023
- Oct 13, 2022: ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
- Sep 07, 2022: ResMed Announces Participation in the Bank of America Global Healthcare Conference
- Sep 06, 2022: ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference
- Aug 11, 2022: ResMed Announces Results for the Fourth Quarter of Fiscal Year 2022
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- ResMed Inc Pipeline Products and Ongoing Clinical Trials Overview
- ResMed Inc Pipeline Products by Equipment Type
- ResMed Inc Pipeline Products by Indication
- ResMed Inc Ongoing Clinical Trials by Trial Status
- ResMed Inc, Key Facts
- ResMed Inc, Major Products and Services
- ResMed Inc Number of Pipeline Products by Development Stage
- ResMed Inc Pipeline Products Summary by Development Stage
- ResMed Inc Ongoing Clinical Trials by Trial Status
- ResMed Inc Ongoing Clinical Trials Summary
- Breezhaler Inhaler - Add On Sensor - Product Status
- Breezhaler Inhaler - Add On Sensor - Product Description
- Connected Metered Dose Inhaler - Product Status
- Connected Metered Dose Inhaler - Product Description
- Leo - Product Status
- Leo - Product Description
- Leo Device - Product Status
- Leo Device - Product Description
- Leo Device - Engineering Validation of Leo Device to Assess Clinical Control of Children Recovering From Acute Asthma Exacerbation
- Masksense - Product Status
- Masksense - Product Description
- Mitigait - Product Status
- Mitigait - Product Description
- Monterey Pneumatic Compression Device - Product Status
- Monterey Pneumatic Compression Device - Product Description
- Smart Device - Cardiac Health - Product Status
- Smart Device - Cardiac Health - Product Description
- ResMed Inc, Key Employees
- ResMed Inc, Key Employee Biographies
- ResMed Inc, Other Locations
- ResMed Inc, Subsidiaries
- Glossary
- ResMed Inc Pipeline Products by Equipment Type
- ResMed Inc Pipeline Products by Development Stage
- ResMed Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Masimo Corp
- Fisher & Paykel Healthcare Corporation Ltd
- Inspire Medical Systems Inc
- Smiths Medical
- Lowenstein
- DeVilbiss Healthcare Ltd
- BMC Medical Co Ltd
- FUJIFILM Medical Systems USA Inc
- Koninklijke Philips NV
- Apex Medical Corp
